Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
14.28
-0.34 (-2.33%)
Nov 21, 2024, 4:00 PM EST - Market closed
Arcus Biosciences Analyst Ratings
Total Analysts
12
Consensus Rating
Buy
Price Target
$34.50
Upside
+141.60%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $20 | Hold | Reiterates | $20 | +40.06% | Nov 6, 2024 |
| Barclays | Barclays | Buy Maintains $25 → $29 | Buy | Maintains | $25 → $29 | +103.08% | Oct 25, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $20 | Hold | Reiterates | $20 | +40.06% | Oct 24, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Initiates $20 | Hold | Initiates | $20 | +40.06% | Oct 21, 2024 |
| Wells Fargo | Wells Fargo | Buy Initiates $29 | Buy | Initiates | $29 | +103.08% | Oct 8, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Oct 7, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Oct 3, 2024 |
| Wedbush | Wedbush | Buy Reiterates $30 | Buy | Reiterates | $30 | +110.08% | Oct 3, 2024 |
| B of A Securities | B of A Securities | Hold Maintains $24 → $23 | Hold | Maintains | $24 → $23 | +61.06% | Aug 9, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 9, 2024 |
| Wedbush | Wedbush | Buy Reiterates $30 | Buy | Reiterates | $30 | +110.08% | Aug 9, 2024 |
| Barclays | Barclays | Buy Maintains $35 → $25 | Buy | Maintains | $35 → $25 | +75.07% | Jul 8, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jul 5, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $50 → $44 | Strong Buy | Maintains | $50 → $44 | +208.12% | Jun 24, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $36 → $38 | Strong Buy | Maintains | $36 → $38 | +166.11% | Jun 3, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $38 → $40 | Buy | Maintains | $38 → $40 | +180.11% | May 13, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.